Tumor-derived MT4-MMP cannot circumvent the absence of a host angio-promoting factor such as the plasminogen activator inhibitor-1 (PAI-1), which cooperates with the uPA/uPAR axis in different contexts [43]. The gene discussed is MT4; the disease is neoplasm.